Aytu BioPharma and Medomie Pharma announced the signing of an exclusive collaboration, distribution and supply agreement for Aytu‘s Adzenys XR-ODT and Cotempla XR-ODT product lines. Medomie will seek local regulatory approvals and marketing authorizations for both Adzenys and Cotempla. This agreement represents Aytu’s first international commercial agreement for Adzenys and Cotempla.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AYTU:
